Malady Kyle
- SEC CIK
- 0001760581
In the past year, 6 open-market sale filings worth $327.9K and no purchases.
Current role at each company
- VZ Verizon Communications IncEVP and Group CEO-VZ Businessas of Sep 23, 2026
- DXCM Dexcom IncDirectoras of Jun 1, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $327.9K
- 6 filings
- Net
- −$327.9K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Malady Kyle as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
VZ Verizon Communications Inc
EVP and Group CEO-VZ Business20 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 23, 2026 (view filing)1:48 PM ET | Sep 22 | 1 day | Malady KyleEVP and Group CEO-VZ Business | SSale | −1.10K | $47.65 | −$52.4K | −1.0%104.4K after | 10b5-1 |
| Sep 16, 2026 (view filing)3:43 PM ET | Sep 15 | 1 day | Malady KyleEVP and Group CEO-VZ Business | SSale | −1.10K | $51.19 | −$56.3K | −1.0%105.5K after | 10b5-1 |
| Sep 9, 2026 (view filing)1:40 PM ET | Sep 8 | 1 day | Malady KyleEVP and Group CEO-VZ Business | SSale | −1.10K | $49.98 | −$55.0K | −1.0%106.6K after | 10b5-1 |
| Sep 2, 2026 (view filing)12:50 PM ET | Sep 1 | 1 day | Malady KyleEVP and Group CEO-VZ Business | SSale | −1.10K | $50.50 | −$55.5K | −1.0%107.7K after | 10b5-1 |
| Aug 26, 2026 (view filing)12:37 PM ET | Aug 25 | 1 day | Malady KyleEVP and Group CEO-VZ Business | SSale | −1.10K | $50.06 | −$55.1K | −1.0%108.8K after | 10b5-1 |
| Aug 19, 2026 (view filing)2:23 PM ET | Aug 18 | 1 day | Malady KyleEVP and Group CEO-VZ Business | SSale | −1.10K | $48.68 | −$53.5K | −1.0%109.9K after | 10b5-1 |
| May 9, 2025 (view filing) | May 8 | 1 day | Malady KyleEVP and Group CEO-VZ Business | SSale | −10.0K | $43.81 | −$438.1K | −99.9%8 after | 2 lots |
| May 8, 2025 (view filing) | May 7 | 1 day | Malady KyleEVP and Group CEO-VZ Business | SSale | −9.00K | $44.10 | −$396.9K | −47.3%10.0K after | |
| May 1, 2025 (view filing) | Apr 30 | 1 day | Malady KyleEVP and Group CEO-VZ Business | SSale | −7.50K | $43.88 | −$329.1K | −28.3%19.0K after | |
| Apr 25, 2025 (view filing) | Apr 24 | 1 day | Malady KyleEVP and Group CEO-VZ Business | SSale | −10.0K | $43.02 | −$430.2K | −27.4%26.5K after |
DXCM Dexcom Inc
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 9, 2025 (view filing) | Sep 5 | 4 days | Malady KyleDirector | SSale | −667 | $80.86 | −$53.9K | −2.9%22.7K after | 10b5-1 |